Atlas Trials

A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission

Clinical trial NCT03281304 · TERMINATED

Trial details

NCT number
NCT03281304
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2017-11-16
Primary completion
2020-02-14
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.